|
CABLES2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.952600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.617000E-01 |
| Normal-vs-Stage2 |
2.242800E-01 |
| Normal-vs-Stage3 |
2.194200E-01 |
| Normal-vs-Stage4 |
6.907800E-01 |
| Stage1-vs-Stage2 |
3.251200E-01 |
| Stage1-vs-Stage3 |
7.974100E-02 |
| Stage1-vs-Stage4 |
8.341400E-01 |
| Stage2-vs-Stage3 |
2.382300E-02 |
| Stage2-vs-Stage4 |
5.171000E-01 |
| Stage3-vs-Stage4 |
1.600600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.753400E-01 |
| Normal-vs-AfricanAmerican |
2.591000E-01 |
| Normal-vs-Asian |
4.037000E-01 |
| Caucasian-vs-AfricanAmerican |
2.302200E-01 |
| Caucasian-vs-Asian |
2.569400E-01 |
| AfricanAmerican-vs-Asian |
1.202380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.184000E-01 |
| Normal-vs-Female |
8.499000E-01 |
| Male-vs-Female |
2.295800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.701600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.318400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.975000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.611000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.272400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.644000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.066400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.509000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.438200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.060000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.043000E-03 |
| Classical-VS-Follicular |
6.196000E-01 |
| Classical-VS-Other |
9.012200E-01 |
| Classical-VS-Normal |
6.518600E-01 |
| Tall-VS-Follicular |
6.556000E-03 |
| Tall-VS-Other |
1.771610E-01 |
| Tall-VS-Normal |
2.869700E-02 |
| Follicular-VS-Other |
7.928400E-01 |
| Follicular-VS-Normal |
4.527400E-01 |
| Other-VS-Normal |
9.818400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.668400E-01 |
| Normal-vs-N1 |
2.392200E-01 |
| N0-vs-N1 |
1.200030E-01 |
|
|
